Diabetes mellitus increases plasma cardiothrophin-1 levels independently of heart failure and hypertension

Basit Öğe Kaydı
dc.authorid0000-0001-7306-5233en_US
dc.authorid0000-0002-3156-1076
dc.contributor.authorAktaş, Gülali
dc.contributor.authorAlçelik, Aytekin
dc.contributor.authorTosun, Mehmet
dc.contributor.authorÖztürk, Serkan
dc.contributor.authorÖzlü, Mehmet Fatih
dc.contributor.authorSavlı, Haluk
dc.contributor.authorYazıcı, Mehmet
dc.date.accessioned2021-06-23T19:34:57Z
dc.date.available2021-06-23T19:34:57Z
dc.date.issued2013
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractAims: Cardiothrophin-1 (CT-1) is a novel 201 amino acid cytokine that has pleiotropic protective effects in apoptosis, hepatic injury, myocardial infection and contrast nephropathy. CT-1 predicts a variety of disorders including atherosclerosis, heart failure, hypertension and cardiomyopathy. However, CT-1 has not been studied previously in diabetic patients without heart failure. The aim of this study was, therefore, to compare CT-1 levels in diabetic and non-diabetic patients. Methods: Thirty-eight patients with type 2 diabetes mellitus and 32 non-diabetic controls have been enrolled into the study. Subjects with severe hypertension, renal diseases, pregnancy and malignancy were excluded. The statistical analysis was performed with SPSS for Windows version 15.0. Results: There were no significant differences between the diabetic and non-diabetic groups with regard to age, hypertension, serum creatinine, systolic and diastolic blood pressure. Median plasma CT-1 was 9.05 (5.70-24.94) pg/ml in diabetic group and 7.16 (5.53-9.64) pg/ml in non-diabetic group (P<0.001). Conclusion: Plasma CT-1 levels increased in diabetic patients independently of hypertension (HT) and heart failure. Prospective studies with a larger cohort are now needed to observe the effects of CT-1 treatment in a diabetic population.en_US
dc.identifier.endpage784en_US
dc.identifier.issn0393-6384
dc.identifier.issue4en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage781en_US
dc.identifier.urihttps://www.actamedicamediterranea.com/archive/2013/medica-4/diabetes-mellitus-increases-plasma-cardiothrophin-levels-independently-of-heart-failure-and-hypertension/document
dc.identifier.urihttps://hdl.handle.net/20.500.12491/7670
dc.identifier.volume29en_US
dc.identifier.wosWOS:000330151200030en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorAktaş, Gülali
dc.institutionauthorAlçelik, Aytekin
dc.institutionauthorTosun, Mehmet
dc.institutionauthorÖztürk, Serkan
dc.institutionauthorÖzlü, Mehmet Fatih
dc.institutionauthorSavlı, Haluk
dc.institutionauthorYazıcı, Mehmet
dc.language.isoenen_US
dc.publisherCarbone Editoreen_US
dc.relation.ispartofActa Medica Mediterraneaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCardiothrophin-1en_US
dc.subjectDiabetes Mellitusen_US
dc.subjectHypertensionen_US
dc.subjectHeart Failureen_US
dc.titleDiabetes mellitus increases plasma cardiothrophin-1 levels independently of heart failure and hypertensionen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
gulali-aktas-7670.pdf
Boyut:
402.56 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin/Full text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
Temel Tıp Bilimleri Bölümü Koleksiyonu